MedMen
Jessica C. has extensive work experience in various roles and industries. Jessica started their career at Marquis Jet as an intern in 2007. Jessica then worked as a Teacher at Susan Sims Bodenstein Preschool from 2008 to 2011.
In 2011, Jessica joined CBRE as an Executive Administrative Assistant, where they worked until 2013. During their time at CBRE, they also held the positions of Senior Administrator of Learning and Development and Ethics and Compliance Manager.
In 2018, Jessica joined MedMen as a Compliance Associate. Jessica quickly advanced to the role of Regulatory Affairs Manager in January 2020 and then became the Senior Compliance and Licensing Manager in June 2020. Throughout their tenure at MedMen, they have been responsible for ensuring compliance with regulations and managing licensing processes.
Overall, Jessica C. has built a diverse background in compliance, regulatory affairs, administration, and education throughout their career.
Jessica C. completed their Bachelor's degree in Sociology from Southern Methodist University in 2005. Jessica then pursued a Bachelor of Arts (BA) degree in Sociology from the University of Southern California from 2005 to 2008. Subsequently, Jessica obtained a Master of Science (MS) degree in Organizational Behavior Studies from New York University in 2011.
MedMen
11 followers
MedMen Enterprises is a leading cannabis company in the U.S. with assets and operations nationwide. MedMen owns and operates licensed cannabis facilities in cultivation, manufacturing and retail, and is the most recognized cannabis brand in the world today. Based in Los Angeles, MedMen employs over 1,100 team members across the U.S. It was founded in 2010 by Adam Bierman and Andrew Modlin, two visionary entrepreneurs who saw not just a tremendous business opportunity in the growing legalization of marijuana, but a chance to redefine our society's relationship with cannabis. The federal prohibition has had a disastrous impact, overpopulating our prisons and enriching violent drug cartels while keeping a relatively benign substance with proven benefits out of the reach of law abiding citizens.